UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 798

Sortiert nach

Effects of ketamine and n-methyl- d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268

Neuroscience, 2003-01, Vol.117 (3), p.697-706

2003

Volltextzugriff (PDF)

Current and Novel Approaches to the Drug Treatment of Schizophrenia

Journal of medicinal chemistry, 2001-02, Vol.44 (4), p.477-501

2001

Volltextzugriff (PDF)

Reduced stress-induced hyperthermia in mGluR5 knockout mice

The European journal of neuroscience, 2002-12, Vol.16 (11), p.2241-2244

2002

Volltextzugriff (PDF)

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

Neuropharmacology, 2005-03, Vol.48 (4), p.492-502

2005

Volltextzugriff (PDF)

The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodents

British journal of pharmacology, 1993-04, Vol.108 (4), p.1156-1163

1993

Volltextzugriff (PDF)

Chromodacryorrhea and repetitive hind paw tapping : models of peripheral and central tachykinin NK1 receptor activation in gerbils

European journal of pharmacology, 1994-03, Vol.253 (3), p.245-252

1994

Volltextzugriff (PDF)

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

Psychopharmacology, 1995-03, Vol.118 (2), p.230-232

1995

Volltextzugriff (PDF)

Competitive and Glycine/NMDA Receptor Antagonists Attenuate Withdrawal-induced Behaviours and Increased Hippocampal Acetylcholine Efflux in Morphine-dependent Rats

Neuropharmacology, 1997-02, Vol.36 (2), p.241-250

1997

Volltextzugriff (PDF)

The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents

The Journal of pharmacology and experimental therapeutics, 1996-05, Vol.277 (2), p.578

1996

Volltextzugriff (PDF)

Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists

Behavioural pharmacology, 2000-09, Vol.11 (6), p.495-504

2000

Volltextzugriff (PDF)

R‐(+)‐HA‐966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

British journal of pharmacology, 1991-08, Vol.103 (4), p.2037-2044

1991

Volltextzugriff (PDF)

Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat

Neuropharmacology, 2000-04, Vol.39 (7), p.1222-1236

2000

Volltextzugriff (PDF)

Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex

The Journal of pharmacology and experimental therapeutics, 1996-11, Vol.279 (2), p.492

1996

Volltextzugriff (PDF)

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies

Neuropharmacology, 2000-11, Vol.39 (12), p.2318

2000

Volltextzugriff (PDF)

The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex

British journal of pharmacology, 1994-11, Vol.113 (3), p.729-736

1994

Volltextzugriff (PDF)

Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor

The Journal of pharmacology and experimental therapeutics, 1997-11, Vol.283 (2), p.636

1997

Volltextzugriff (PDF)

The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig

Neuropharmacology, 1995-04, Vol.34 (4), p.383-392

1995

Volltextzugriff (PDF)

Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

Trends in pharmacological sciences (Regular ed.), 1997-06, Vol.18 (6), p.186-188

1997

Volltextzugriff (PDF)

Biphasic effects of intra‐accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors

British journal of pharmacology, 1988-12, Vol.95 (4), p.1292-1302

1988

Volltextzugriff (PDF)

Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

Neuropharmacology, 2000-06, Vol.39 (7), p.1222-1236

2000

Volltextzugriff (PDF)

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies

Neuropharmacology, 2000-11, Vol.39 (12), p.2318-2328

2000

Volltextzugriff (PDF)

Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition

Brain research, 2008-03, Vol.1197, p.47-62

2008

Volltextzugriff (PDF)

L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests

The Journal of pharmacology and experimental therapeutics, 1997-12, Vol.283 (3), p.1256

1997

Volltextzugriff (PDF)

Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907 : role of presynaptic dopamine D2 autoreceptors

Neuropharmacology, 1998-06, Vol.37 (6), p.793-802

1998

Volltextzugriff (PDF)

Genetic knockout and pharmacological blockade studies of the 5-HT 7 receptor suggest therapeutic potential in depression

Neuropharmacology, 2005, Vol.48 (4), p.492-502

2005

Volltextzugriff (PDF)

1 – 25 von 798

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(745)
Mit Volltextzugriff
(699)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(495)
Life Sciences & Biomedicine
(375)
Humans
(281)
Biological And Medical Sciences
(184)
Male
(174)
Female
(151)
Medical Sciences
(138)
Animals
(122)
Physical Sciences
(109)
Middle Aged
(99)
Adult
(88)
Cardiovascular System & Cardiology
(72)
Cardiac & Cardiovascular Systems
(71)
Aged
(68)
Oncology
(62)
Rats
(58)
Pharmacology. Drug Treatments
(57)
Fundamental And Applied Biological Sciences. Psychology
(52)
Mice
(52)
Pharmacology & Pharmacy
(51)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Effects of ketamine and n-methyl- d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268

Current and Novel Approaches to the Drug Treatment of Schizophrenia

Reduced stress-induced hyperthermia in mGluR5 knockout mice

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodents

Chromodacryorrhea and repetitive hind paw tapping : models of peripheral and central tachykinin NK1 receptor activation in gerbils

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

Competitive and Glycine/NMDA Receptor Antagonists Attenuate Withdrawal-induced Behaviours and Increased Hippocampal Acetylcholine Efflux in Morphine-dependent Rats

The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents

Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists

R‐(+)‐HA‐966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat

Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies

The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex

Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor

The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig

Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

Biphasic effects of intra‐accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors

Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies

Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition

L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests

Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907 : role of presynaptic dopamine D2 autoreceptors

Genetic knockout and pharmacological blockade studies of the 5-HT 7 receptor suggest therapeutic potential in depression

Suchergebnisse filtern